Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NLRP3 inflammasome is a multiprotein complex crucial for the innate immune system. It senses both pathogen-associated and damage-associated molecular patterns, triggering inflammatory responses through caspase-1 activation and the maturation of pro-inflammatory cytokines like IL-1β and IL-18. Dysregulation of the NLRP3 inflammasome is implicated in various diseases, making it a therapeutic target for inflammation-driven conditions. The inhibitor MCC950 binds within the NACHT domain cavity distinct from nucleotide binding sites, stabilizing inactive conformations.
Inhibition of NLRP3 inflammasome assembly and activation, stabilization of inactive conformations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NLR Family Pyrin Domain Containing 3 Inflammasome (NLRP3).